Amir, M. et al. 2022. UTILITY OF INFLAMMATORY MARKERS FOR TOCILIZUMAB IN COVID-19 PATIENTS: A SINGLE-SITE RETROSPECTIVE STUDY. Journal of Ayub Medical College Abbottabad. 34, 4 (Sep. 2022), 781–785. DOI:https://doi.org/10.55519/JAMC-04-10565.